1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prostate Specific Antigen Test (PSA)
1.2.3 Digital Rectal Exam (DRE)
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2017-2028)
2.2 Prostate Cancer Diagnosis and Treatment Growth Trends by Region
2.2.1 Prostate Cancer Diagnosis and Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Size by Region (2017-2022)
2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Region (2023-2028)
2.3 Prostate Cancer Diagnosis and Treatment Market Dynamics
2.3.1 Prostate Cancer Diagnosis and Treatment Industry Trends
2.3.2 Prostate Cancer Diagnosis and Treatment Market Drivers
2.3.3 Prostate Cancer Diagnosis and Treatment Market Challenges
2.3.4 Prostate Cancer Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2017-2022)
3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue
3.4 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2021
3.5 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnosis and Treatment Breakdown Data by Type
4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2017-2022)
4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Diagnosis and Treatment Breakdown Data by Application
5.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Application (2017-2022)
5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
6.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Type
6.2.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
6.2.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2023-2028)
6.2.3 North America Prostate Cancer Diagnosis and Treatment Market Share by Type (2017-2028)
6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Application
6.3.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
6.3.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2023-2028)
6.3.3 North America Prostate Cancer Diagnosis and Treatment Market Share by Application (2017-2028)
6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Country
6.4.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
6.4.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
7.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type
7.2.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
7.2.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2023-2028)
7.2.3 Europe Prostate Cancer Diagnosis and Treatment Market Share by Type (2017-2028)
7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application
7.3.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
7.3.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2023-2028)
7.3.3 Europe Prostate Cancer Diagnosis and Treatment Market Share by Application (2017-2028)
7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country
7.4.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
7.4.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
9.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type
9.2.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Prostate Cancer Diagnosis and Treatment Market Share by Type (2017-2028)
9.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application
9.3.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Prostate Cancer Diagnosis and Treatment Market Share by Application (2017-2028)
9.4 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country
9.4.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size (2017-2028)
10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction
11.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.2.5 AbbVie Recent Developments
11.3 Active Biotech
11.3.1 Active Biotech Company Details
11.3.2 Active Biotech Business Overview
11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction
11.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.3.5 Active Biotech Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction
11.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.4.5 Amgen Recent Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction
11.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.5.5 Astellas Pharma Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction
11.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Details
11.7.2 Bavarian Nordic Business Overview
11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction
11.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.7.5 Bavarian Nordic Recent Developments
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction
11.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.8.5 Bayer Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Developments
11.10 Dendreon
11.10.1 Dendreon Company Details
11.10.2 Dendreon Business Overview
11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction
11.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.10.5 Dendreon Recent Developments
11.11 Endo
11.11.1 Endo Company Details
11.11.2 Endo Business Overview
11.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction
11.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.11.5 Endo Recent Developments
11.12 Ferring Pharmaceuticals
11.12.1 Ferring Pharmaceuticals Company Details
11.12.2 Ferring Pharmaceuticals Business Overview
11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
11.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.12.5 Ferring Pharmaceuticals Recent Developments
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction
11.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.13.5 GE Healthcare Recent Developments
11.14 GSK
11.14.1 GSK Company Details
11.14.2 GSK Business Overview
11.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction
11.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.14.5 GSK Recent Developments
11.15 Ipsen
11.15.1 Ipsen Company Details
11.15.2 Ipsen Business Overview
11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction
11.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.15.5 Ipsen Recent Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Details
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction
11.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.16.5 Johnson & Johnson Recent Developments
11.17 Pfizer
11.17.1 Pfizer Company Details
11.17.2 Pfizer Business Overview
11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction
11.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.17.5 Pfizer Recent Developments
11.18 Sanofi
11.18.1 Sanofi Company Details
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction
11.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.18.5 Sanofi Recent Developments
11.19 Siemens Healthineers
11.19.1 Siemens Healthineers Company Details
11.19.2 Siemens Healthineers Business Overview
11.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction
11.19.4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.19.5 Siemens Healthineers Recent Developments
11.20 Takeda
11.20.1 Takeda Company Details
11.20.2 Takeda Business Overview
11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction
11.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.20.5 Takeda Recent Developments
11.21 Teva Pharmaceutical
11.21.1 Teva Pharmaceutical Company Details
11.21.2 Teva Pharmaceutical Business Overview
11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction
11.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.21.5 Teva Pharmaceutical Recent Developments
11.22 Tolmar Pharmaceuticals
11.22.1 Tolmar Pharmaceuticals Company Details
11.22.2 Tolmar Pharmaceuticals Business Overview
11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction
11.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2017-2022)
11.22.5 Tolmar Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
